Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

NCT04416490 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
2013
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boryung Pharmaceutical Co., Ltd